Why work with us?
RS Research is a clinical-stage biotechnology start-up, developing innovative therapies to win the fight against cancer. Our novel drug delivery technology promises a “cure with a smile” for patients.
Following our seed investment in 2017, we are now celebrating a $12 Million Series-A investment round, ranking us in the top 10 largest start-up investments in Turkey for 2021. We are proud to place a biotech company in this “top investments” list for the first time.
Reaching #47 in the 2021 Startup Turkey list, RS Research has been internationally recognized on many platforms: we are the Hello Tomorrow Turkey 2020 Grand Prize winner and Hello Tomorrow Global Summit 2021 Drug Discovery finalist. Our inspiring Co-Founder Prof. Rana Sanyal has been named one of the three Cartier Women’s Initiative 2021 Global Science & Technology Pioneer fellows.
Based in Istanbul and Lausanne, RS Research is now ready to take the next steps to become a global player in drug development. We are at the doorsteps of many exciting achievements.
From clinical development of our pipeline to international co-development opportunities, our roadmap is decorated with a number of priceless opportunities for change makers who cannot imagine a life without achievement, adrenaline, and celebration.
We are looking forward to welcoming outside the box thinking new members to our brilliant team of experts.
Explore the opportunities to be a part of a brilliant multidisciplinary team.